{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T19:08:13Z","timestamp":1785784093478,"version":"3.56.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,24]]},"DOI":"10.7759\/cureus.63019","type":"journal-article","created":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T10:48:18Z","timestamp":1719226098000},"source":"Crossref","is-referenced-by-count":5,"title":["Relationship Between Metabolic Dysfunction-Associated Steatotic Liver Disease and Lipoprotein (a) and Other Biomarkers"],"prefix":"10.7759","author":[{"given":"Felipe A.","family":"Mu\u00f1oz Rossi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juanita","family":"Salazar Agudelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N\u00e9stor Israel","family":"Quinapanta Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sof\u00eda Z.","family":"Mosquera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Clara","family":"Mejia Fajardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgar Dario","family":"Mosquera L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan Dany","family":"Espitia Olarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Andrea","family":"Figueroa Medina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin","family":"Zuniga Simancas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Fernando","family":"Saldarriaga Osuna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.7570\/jomes22021","article-title":"Recent epidemiology and risk factors of nonalcoholic fatty liver disease","volume":"31","author":"Huh Y","year":"2022","unstructured":"Huh Y, Cho YJ, Nam GE. Recent epidemiology and risk factors of nonalcoholic fatty liver disease. J Obes Metab Syndr. 2022, 31:17-27. 10.7570\/jomes22021","journal-title":"J Obes Metab Syndr"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.7570\/jomes23052","article-title":"Metabolic dysfunction-associated steatotic liver disease (MASLD): a state-of-the-art review","volume":"32","author":"Chan WK","year":"2023","unstructured":"Chan WK, Chuah KH, Rajaram RB, Lim LL, Ratnasingam J, Vethakkan SR. Metabolic dysfunction-associated steatotic liver disease (MASLD): a state-of-the-art review. J Obes Metab Syndr. 2023, 32:197-213. 10.7570\/jomes23052","journal-title":"J Obes Metab Syndr"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi ZM","year":"2016","unstructured":"Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016, 64:73-84. 10.1002\/hep.28431","journal-title":"Hepatology"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/apt.14506","article-title":"Clinical features and treatment of nonalcoholic fatty liver disease across the Asia Pacific region-the GO ASIA initiative","volume":"47","author":"Chan WK","year":"2018","unstructured":"Chan WK, Treeprasertsuk S, Imajo K, et al.. Clinical features and treatment of nonalcoholic fatty liver disease across the Asia Pacific region-the GO ASIA initiative. Aliment Pharmacol Ther. 2018, 47:816-25. 10.1111\/apt.14506","journal-title":"Aliment Pharmacol Ther"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.120.315291","article-title":"Lp(a) (lipoprotein[a]) concentrations and incident atherosclerotic cardiovascular disease: new insights from a large national biobank","volume":"41","author":"Patel AP","year":"2021","unstructured":"Patel AP, Wang M, Pirruccello JP, Ellinor PT, Ng K, Kathiresan S, Khera AV. Lp(a) (lipoprotein[a]) concentrations and incident atherosclerotic cardiovascular disease: new insights from a large national biobank. Arterioscler Thromb Vasc Biol. 2021, 41:465-74. 10.1161\/ATVBAHA.120.315291","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2009.1063","article-title":"Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality","volume":"302","author":"Erqou S","year":"2009","unstructured":"Erqou S, Kaptoge S, Perry PL, et al.. Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality. JAMA. 2009, 302:412-23. 10.1001\/jama.2009.1063","journal-title":"JAMA"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.09.038","article-title":"Elevated lipoprotein(a) and risk of aortic valve stenosis in the general population","volume":"63","author":"Kamstrup PR","year":"2014","unstructured":"Kamstrup PR, Tybj\u00e6rg-Hansen A, Nordestgaard BG. Elevated lipoprotein(a) and risk of aortic valve stenosis in the general population. J Am Coll Cardiol. 2014, 63:470-7. 10.1016\/j.jacc.2013.09.038","journal-title":"J Am Coll Cardiol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2019.10.019","article-title":"Lipoprotein(a) concentration and risks of cardiovascular disease and diabetes","volume":"74","author":"Gudbjartsson DF","year":"2019","unstructured":"Gudbjartsson DF, Thorgeirsson G, Sulem P, et al.. Lipoprotein(a) concentration and risks of cardiovascular disease and diabetes. J Am Coll Cardiol. 2019, 74:2982-94. 10.1016\/j.jacc.2019.10.019","journal-title":"J Am Coll Cardiol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2020.02.026","article-title":"Advanced fibrosis of non-alcoholic steatohepatitis affects the significance of lipoprotein(a) as a cardiovascular risk factor","volume":"299","author":"Konishi K","year":"2020","unstructured":"Konishi K, Miyake T, Furukawa S, et al.. Advanced fibrosis of non-alcoholic steatohepatitis affects the significance of lipoprotein(a) as a cardiovascular risk factor. Atherosclerosis. 2020, 299:32-7. 10.1016\/j.atherosclerosis.2020.02.026","journal-title":"Atherosclerosis"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2020.07.020","article-title":"Serum lipoprotein(a) levels and insulin resistance have opposite effects on fatty liver disease","volume":"308","author":"Jung I","year":"2020","unstructured":"Jung I, Kwon H, Park SE, et al.. Serum lipoprotein(a) levels and insulin resistance have opposite effects on fatty liver disease. Atherosclerosis. 2020, 308:1-5. 10.1016\/j.atherosclerosis.2020.07.020","journal-title":"Atherosclerosis"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2010.09.038","article-title":"Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study","volume":"140","author":"Williams CD","year":"2011","unstructured":"Williams CD, Stengel J, Asike MI, et al.. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology. 2011, 140:124-31. 10.1053\/j.gastro.2010.09.038","journal-title":"Gastroenterology"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1590\/s1516-31802007000600006","article-title":"Non-alcoholic fatty liver disease and metabolic syndrome in Brazilian middle-aged and older adults","volume":"125","author":"Karnikowski M","year":"2007","unstructured":"Karnikowski M, C\u00f3rdova C, Oliveira RJ, Karnikowski MG, N\u00f3brega Ode T. Non-alcoholic fatty liver disease and metabolic syndrome in Brazilian middle-aged and older adults. Sao Paulo Med J. 2007, 125:333-7. 10.1590\/s1516-31802007000600006","journal-title":"Sao Paulo Med J"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2010.11.021","article-title":"Nonalcoholic fatty liver disease is associated with insulin resistance in a young Hispanic population","volume":"52","author":"Perez M","year":"2011","unstructured":"Perez M, Gonz\u00e1les L, Olarte R, et al.. Nonalcoholic fatty liver disease is associated with insulin resistance in a young Hispanic population. Prev Med. 2011, 52:174-7. 10.1016\/j.ypmed.2010.11.021","journal-title":"Prev Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-3111","article-title":"Hepatic steatosis and insulin resistance, but not steatohepatitis, promote atherogenic dyslipidemia in NAFLD","volume":"101","author":"Bril F","year":"2016","unstructured":"Bril F, Sninsky JJ, Baca AM, et al.. Hepatic steatosis and insulin resistance, but not steatohepatitis, promote atherogenic dyslipidemia in NAFLD. J Clin Endocrinol Metab. 2016, 101:644-52. 10.1210\/jc.2015-3111","journal-title":"J Clin Endocrinol Metab"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1186\/s13098-021-00741-5","article-title":"Association of anti-oxidative capacity of HDL with subclinical atherosclerosis in subjects with and without non-alcoholic fatty liver disease","volume":"13","author":"Karami S","year":"2021","unstructured":"Karami S, Poustchi H, Sarmadi N, Radmard AR, Ali Yari F, Pakdel A, Shabani P. Association of anti-oxidative capacity of HDL with subclinical atherosclerosis in subjects with and without non-alcoholic fatty liver disease. Diabetol Metab Syndr. 2021, 13:121. 10.1186\/s13098-021-00741-5","journal-title":"Diabetol Metab Syndr"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2013.01.022","article-title":"Nonalcoholic fatty liver disease and serum lipoproteins: the multi-ethnic study of atherosclerosis","volume":"227","author":"DeFilippis AP","year":"2013","unstructured":"DeFilippis AP, Blaha MJ, Martin SS, et al.. Nonalcoholic fatty liver disease and serum lipoproteins: the multi-ethnic study of atherosclerosis. Atherosclerosis. 2013, 227:429-36. 10.1016\/j.atherosclerosis.2013.01.022","journal-title":"Atherosclerosis"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.34921","article-title":"Relationship between vitamin D deficiency and non-alcoholic fatty liver disease: a cross-sectional study from a tertiary care center in northern India","volume":"15","author":"Kumar M","year":"2023","unstructured":"Kumar M, Parchani A, Kant R, Das A. Relationship between vitamin D deficiency and non-alcoholic fatty liver disease: a cross-sectional study from a tertiary care center in northern India. Cureus. 2023, 15:e34921. 10.7759\/cureus.34921","journal-title":"Cureus"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.4103\/ijpvm.IJPVM_499_17","article-title":"Effect of vitamin D on non-alcoholic fatty liver disease: a systematic review of randomized controlled clinical trials","volume":"10","author":"Hariri M","year":"2019","unstructured":"Hariri M, Zohdi S. Effect of vitamin D on non-alcoholic fatty liver disease: a systematic review of randomized controlled clinical trials. Int J Prev Med. 2019, 10:14. 10.4103\/ijpvm.IJPVM_499_17","journal-title":"Int J Prev Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-020-01369-x","article-title":"Frequently abnormal serum gamma-glutamyl transferase activity is associated with future development of fatty liver: a retrospective cohort study","volume":"20","author":"Fujii H","year":"2020","unstructured":"Fujii H, Doi H, Ko T, et al.. Frequently abnormal serum gamma-glutamyl transferase activity is associated with future development of fatty liver: a retrospective cohort study. BMC Gastroenterol. 2020, 20:217. 10.1186\/s12876-020-01369-x","journal-title":"BMC Gastroenterol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/hep4.1830","article-title":"Low lipoprotein(a) levels predict hepatic fibrosis in patients with nonalcoholic fatty liver disease","volume":"6","author":"Meroni M","year":"2022","unstructured":"Meroni M, Longo M, Lombardi R, et al.. Low lipoprotein(a) levels predict hepatic fibrosis in patients with nonalcoholic fatty liver disease. Hepatol Commun. 2022, 6:535-49. 10.1002\/hep4.1830","journal-title":"Hepatol Commun"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2016.07.003","article-title":"Association between lipoprotein(a) and nonalcoholic fatty liver disease among Korean adults","volume":"461","author":"Nam JS","year":"2016","unstructured":"Nam JS, Jo S, Kang S, Ahn CW, Kim KR, Park JS. Association between lipoprotein(a) and nonalcoholic fatty liver disease among Korean adults. Clin Chim Acta. 2016, 461:14-8. 10.1016\/j.cca.2016.07.003","journal-title":"Clin Chim Acta"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/261998-relationship-between-metabolic-dysfunction-associated-steatotic-liver-disease-and-lipoprotein-a-and-other-biomarkers","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T10:48:28Z","timestamp":1719226108000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/261998-relationship-between-metabolic-dysfunction-associated-steatotic-liver-disease-and-lipoprotein-a-and-other-biomarkers"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,24]]},"references-count":21,"URL":"https:\/\/doi.org\/10.7759\/cureus.63019","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6,24]]}}}